Reduced neutralization of SARS-CoV-2 B.1.617 variant by inactivated and RBD-subunit vaccine
J. Hu, X.-y. Wei, J. Xiang, P. Peng, F.-l. Xu, K. Wu, F.-y. Luo, A.-s. Jin, L. Fang, B.-z. Liu, K. Wang, N. Tang, A. Huang
The paper evaluates the neutralization efficacy of inactivated and RBD-subunit vaccines against SARS-CoV-2 B.1.617 and B.1.1.7 variants using a pseudovirus-based assay.
bioRxiv · Jul 9, 2021 · PreprintMicrobiology